Cingulate (CING) Income from Non-Controlling Interests (2022 - 2026)
Cingulate's (CING) quarterly Income from Non-Controlling Interests came in at $1.0 in Q2 2026, up 100.12% on a YoY basis from $0.5 in Q2 2025, and up 100.0% quarter-over-quarter from -$518229.0 in Q4 2025.
Powered by 
Analysis
Cingulate (CING) Income from Non-Controlling Interests (2022 - 2026) Analysis & Trends
Cingulate (CING) has reported Income from Non-Controlling Interests for 5 consecutive years, with $1.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Income from Non-Controlling Interests rose 100.12% year-over-year to $1.0; the trailing twelve-month figure through Jun 2026 stood at -$2719.0 (up 69.02% YoY), and the FY2025 full-year result was -$1863.0, up 95.01% from the prior year.
- Income from Non-Controlling Interests climbed to $1.0 in Q2 2026 per CING's latest filing, from -$518229.0 in the prior quarter.
- Across five years, Income from Non-Controlling Interests topped out at $516366.0 in Q3 2025 and bottomed at -$518229.0 in Q4 2025.
- Historically, Income from Non-Controlling Interests has averaged -$9293.9 across 5 years, with a median of -$8599.0 in 2022.
- The widest YoY moves for Income from Non-Controlling Interests: up 949.14% in 2025, down 811.08% in 2025.
- Over 5 years, Income from Non-Controlling Interests stood at $74679.0 in 2022, then sank by 68.68% to $23387.0 in 2023, then slumped by 343.22% to -$56881.0 in 2024, then slumped by 811.08% to -$518229.0 in 2025, then surged by 100.0% to $1.0 in 2026.
- According to Business Quant data, Income from Non-Controlling Interests over the past three periods registered $1.0, -$518229.0, and $516366.0 for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 650.65 Bn | 629.89 Bn | 17.26 Bn | - |
| 2 | AbbVie | 466.34 Bn | 459.82 Bn | 12.70 Bn | 3.00 Mn |
| 3 | Merck | 362.11 Bn | 355.02 Bn | 12.21 Bn | -2.00 Mn |
| 4 | Novartis Ag | 267.81 Bn | 260.52 Bn | 11.24 Bn | -7.00 Mn |
| 5 | Pfizer | 157.31 Bn | 145.91 Bn | 10.94 Bn | 10.00 Mn |
| 6 | Bristol Myers Squibb | 128.75 Bn | 117.69 Bn | 9.25 Bn | -1.00 Mn |
| 7 | Sanofi | 51.80 Bn | 44.84 Bn | 10.79 Bn | 39.52 Mn |
| 8 | Revolution Medicines | 40.91 Bn | 40.91 Bn | - | - |
| 9 | BeOne Medicines | 39.65 Bn | 34.55 Bn | 1.53 Bn | - |
| 10 | Cingulate | 72.81 Mn | 72.81 Mn | - | 1.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.00 |
| Dec 31, 2025 | -518,229.00 |
| Sep 30, 2025 | 516,366.00 |
| Jun 30, 2025 | -857.00 |
| Mar 31, 2025 | -257.00 |
| Dec 31, 2024 | -56,881.00 |
| Sep 30, 2024 | 49,218.00 |
| Jun 30, 2024 | 1,269.00 |
| Mar 31, 2024 | -30,917.00 |
| Dec 31, 2023 | 23,387.00 |
| Sep 30, 2023 | -17,469.00 |
| Jun 30, 2023 | -35,864.00 |
| Mar 31, 2023 | -32,009.00 |
| Dec 31, 2022 | 74,679.00 |
| Sep 30, 2022 | -67,623.00 |
| Jun 30, 2022 | -8,599.00 |
| Mar 31, 2022 | -54,212.00 |
API Access
Cingulate Income from Non-Controlling Interests API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=CING&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-from-non-controlling-interests", "ticker": "CING", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=CING&period=max&api_key=YOUR_API_KEY");
const data = await res.json();